Associated Papers
Risk category system to identify pituitary adenoma patients with AIP mutations.
Caimari F et al.
Journal of Medical Genetics, 2018
29440248 (PubMed )
Supplement: jmedgenet-2017-104957supp001.docx
Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene.
Beckers A et al.
Endocrine Reviews, 2013
Familial isolated pituitary adenomas: an emerging clinical entity.
Martucci F et al.
Journal of Endocrinological Investigation, 2012
Germline AIP mutations in apparently sporadic pituitary adenomas: prevalence in a prospective single-center cohort of 443 patients.
Cazabat L et al.
The Journal of Clinical Endocrinology and Metabolism, 2012
Familial isolated pituitary adenomas: from genetics to therapy.
Guaraldi F et al.
Clinical and Translational Science, 2011
AIP gene and familial isolated pituitary adenomas.
Ozfirat Z et al.
Molecular and Cellular Endocrinology, 2010
Role of the aryl hydrocarbon receptor-interacting protein in familial isolated pituitary adenoma.
Cain JW et al.
Expert Review of Endocrinology & Metabolism, 2010
Mutations of the gene for the aryl hydrocarbon receptor-interacting protein in pituitary adenomas.
Cazabat L et al.
Hormone Research, 2009
Characteristics of familial isolated pituitary adenomas.
Daly AF et al.
Expert Review of Endocrinology & Metabolism, 2007
Germline inactivating mutations of the aryl hydrocarbon receptor-interacting protein gene in a large cohort of sporadic acromegaly: mutations are found in a subset of young patients with macroadenomas.
Cazabat L et al.
European Journal of Endocrinology, 2007
Select a paper to view details